Michael Fischer is a Nephrology physician. ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1740 W Taylor St
Chicago, IL 606127232
Telephone
866-600-2273Registry record last updated 14 Dec 2011.
Clinical trials
- Pain Induced by m-Cresol as Preservative
Sponsor: Medical University of Vienna
- The Role of NaV1.8 in Human Pain Models
Sponsor: Medical University of Vienna
- Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
Sponsor: Boston Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.1%Calcium channel blocker32.6%Amlodipine Besylate100%Part D<11 patientsACE inhibitor25.6%Lisinopril100%Part D<11 patientsOther
41.9%Phosphate Binder41.9%Sevelamer Carbonate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2019–2020 per NIH RePORTER. The latest:
- University of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical Center
University of Illinois at Chicago
FY2020$147,748U01DK123787 - University of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical Center
University of Illinois at Chicago
FY2019$2,845,360U01DK123787
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”